U.S. to resume J&J COVID-19 vaccinations despite rare clot risk
The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot
from The Hindu - News https://ift.tt/2QT6N2C
from The Hindu - News https://ift.tt/2QT6N2C
Comments
Post a Comment